TY - JOUR
T1 - Reduced mortality during the COVID-19 outbreak in Japan, 2020
T2 - A two-stage interrupted time-series design
AU - Onozuka, Daisuke
AU - Tanoue, Yuta
AU - Nomura, Shuhei
AU - Kawashima, Takayuki
AU - Yoneoka, Daisuke
AU - Eguchi, Akifumi
AU - Ng, Chris Fook Sheng
AU - Matsuura, Kentaro
AU - Shi, Shoi
AU - Makiyama, Koji
AU - Uryu, Shinya
AU - Kawamura, Yumi
AU - Takayanagi, Shinichi
AU - Gilmour, Stuart
AU - Hayashi, Takehiko I.
AU - Miyata, Hiroaki
AU - Sera, Francesco
AU - Sunagawa, Tomimasa
AU - Takahashi, Takuri
AU - Tsuchihashi, Yuuki
AU - Kobayashi, Yusuke
AU - Arima, Yuzo
AU - Kanou, Kazuhiko
AU - Suzuki, Motoi
AU - Hashizume, Masahiro
N1 - Publisher Copyright:
© 2021 The Author(s) 2021. Published by Oxford University Press on behalf of the International Epidemiological Association.
PY - 2022/2/1
Y1 - 2022/2/1
N2 - Coronavirus disease 2019 (COVID-19) continues to be a major global health burden. This study aims to estimate the all-cause excess mortality occurring in the COVID-19 outbreak in Japan, 2020, by sex and age group. Methods: Daily time series of mortality for the period January 2015-December 2020 in all 47 prefectures of Japan were obtained from the Ministry of Health, Labour and Welfare, Japan. A two-stage interrupted time-series design was used to calculate excess mortality. In the first stage, we estimated excess mortality by prefecture using quasi-Poisson regression models in combination with distributed lag non-linear models, adjusting for seasonal and long-term variations, weather conditions and influenza activity. In the second stage, we used a random-effects multivariate meta-analysis to synthesize prefecture-specific estimates at the nationwide level. Results: In 2020, we estimated an all-cause excess mortality of -20 982 deaths [95% empirical confidence intervals (eCI): -38 367 to -5472] in Japan, which corresponded to a percentage excess of -1.7% (95% eCI: -3.1 to -0.5) relative to the expected value. Reduced deaths were observed for both sexes and in all age groups except those aged <60 and 70-79 years. Conclusions: All-cause mortality during the COVID-19 outbreak in Japan in 2020 was decreased compared with a historical baseline. Further evaluation of cause-specific excess mortality is warranted.
AB - Coronavirus disease 2019 (COVID-19) continues to be a major global health burden. This study aims to estimate the all-cause excess mortality occurring in the COVID-19 outbreak in Japan, 2020, by sex and age group. Methods: Daily time series of mortality for the period January 2015-December 2020 in all 47 prefectures of Japan were obtained from the Ministry of Health, Labour and Welfare, Japan. A two-stage interrupted time-series design was used to calculate excess mortality. In the first stage, we estimated excess mortality by prefecture using quasi-Poisson regression models in combination with distributed lag non-linear models, adjusting for seasonal and long-term variations, weather conditions and influenza activity. In the second stage, we used a random-effects multivariate meta-analysis to synthesize prefecture-specific estimates at the nationwide level. Results: In 2020, we estimated an all-cause excess mortality of -20 982 deaths [95% empirical confidence intervals (eCI): -38 367 to -5472] in Japan, which corresponded to a percentage excess of -1.7% (95% eCI: -3.1 to -0.5) relative to the expected value. Reduced deaths were observed for both sexes and in all age groups except those aged <60 and 70-79 years. Conclusions: All-cause mortality during the COVID-19 outbreak in Japan in 2020 was decreased compared with a historical baseline. Further evaluation of cause-specific excess mortality is warranted.
KW - All-cause death
KW - COVID-19
KW - Japan
KW - excess mortality
KW - two-stage interrupted time-series design
UR - http://www.scopus.com/inward/record.url?scp=85122799626&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122799626&partnerID=8YFLogxK
U2 - 10.1093/ije/dyab216
DO - 10.1093/ije/dyab216
M3 - Article
C2 - 34718594
AN - SCOPUS:85122799626
SN - 0300-5771
VL - 51
SP - 75
EP - 84
JO - International Journal of Epidemiology
JF - International Journal of Epidemiology
IS - 1
ER -